NCT02015403View on ClinicalTrials.gov

To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed

NACompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Ischemic Hepatitis

Interventions

DRUG

Standard Care + NAC (N -ACETYLCYSTEINE)

DRUG

Standard Care (in control arm)

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02015403 - To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed | Biotech Hunter | Biotech Hunter